The press release said: "Generex Biotechnology Cor
Post# of 36537
(Total Views: 305)
Posted On: 04/14/2021 12:31:42 PM
The press release said: "Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) ("Generex" or the "Company"
, an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative "Complete Vaccine" to fight SARS-CoV-2, today announced the company has submitted a response package to the FDA's comments in their Pre-IND Written Response." Emphasis on "has submitted." So, on what basis do you continue to say "with it still pending to be submitted?"
, an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative "Complete Vaccine" to fight SARS-CoV-2, today announced the company has submitted a response package to the FDA's comments in their Pre-IND Written Response." Emphasis on "has submitted." So, on what basis do you continue to say "with it still pending to be submitted?"
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼